15Oct 2019

EXPRESSION OF VEGF IN BREAST CANCER

  • Senior Consultant, Department of Health, Government of Jammu & Kashmir, Anantnag, Jammu & Kashmir.
  • Assistant Professor, Department of Pathology, Government Medical College, Anantnag, Jammu & Kashmir, India.
  • Assistant Professor, Department of Pathology, Government Medical College, Doda, Jammu & Kashmir, India.
  • Senior Resident, Department of Pathology, Government Medical College, Anantnag, Jammu & Kashmir, India.
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Aim: Breast Cancer is the most frequent cancer in India. Tumor angiogenesis has been considered as a crucial step in the cancer development and progression. Vascular endothelial growth factor (VEGF) is one important prognostic marker in patients with breast cancer .The aim of the study is to see the expression of VEGF in breast cancers by immunohistochemistry. . Materials and methods: Formalin fixed paraffin embedded sections of 100 cases of malignant breast lesions were taken up for the study and subjected to immunohistochemistry using VEGF. Results: The intensity of VEGF immunostaining in malignant breast lesions was evaluated and scoring was graded as 0,1+,2+,3+ and 4+. Statistical analysis was performed with Chi-Square test and significant differences were noted between these 3 groups (p value< 0.05). Conclusion: VEGF expression correlated well with the grade and stages of tumor indicating that VEGF positive tumors are biologically aggressive and are associated with poor prognosis.


  1. Giampietro GaspariniEmanuela Bonoldi?Carlo Gatti?Orazio Vinante?Masakazu ToiTakeshi Tominaga?Massimo Gion?Ruggero Dittadi?Paolo Verderio?Patrizia BoracchiMitsuya Hanatani?Isamu Matsubara?Hideo Suzuki. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. Journal of the National Cancer Institute 1997; 89: 39-47.
  2. Sophia K, Apple J, Randolph H, et al. Immunohistochemical evaluation of K-ras, p53 and HER-2/neu expression in hyperplastic, dysplastic and carcinomatous lesions of the pancreas: evidence for multistep carcinogenesis. Human Pathology 1999;30:123-130.
  3. Melanie Schmidt et al(2008), Expression of VEGF-R1 in Breast cancer is associated with VEGF expression and Node negative tumor stage, Anticancer Research 28:1719-1724.
  4. AL-Harris ES. Overexpression of VEGF in Correlation to Ki-67 grade and stage of breast cancer. Saudi Medical Journal 2008.Vol.29(8):page 477-482.
  5. Anca Maria Cimpean et al (2008), Correlation of VEGF with recurrences, survival, and first relapse site in primary breast cancer after adjuvant treatment. J Of Clin Oncol 2008;18(7):1423- 1431.
  6. Linderholm B, Lindg B and Tavelin B. p53 and vascular endothelial growth factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma. Int J Cancer2000;89:51-62.
  7. Shankar RS, Tiwary K, Khanna R, et al. Tumor Angiogenesis: Determined By VEGF Expression, MAGS Scoring, Doppler Study, In Carcinoma Breast. The Int J Surgery. 2006; 8:No.1.
  8. Gottfried E. Konecny, Glosia YM, Michael U, et al. Association between HER-2/neu and VEGF expression predicts clinical outcome in primary breast cancer patients. Clin Can Res 2004;10:1706-1716.
  9. Collagy G, Dimitriadis E, Harmey J, et al. Immunohistochemical measurement of tumor VEGF in breast cancer ,a more reliable predictor of tumor stage than Microvessel density or serum VEGF. Appl Immunohistochemical Mol Morphol 2000 Jun;8(2):104-113.
  10. Bolat F, Kayaselcuk F, Nursal TZ, et al. Microvessel density, VEGF expression, and tumor associated macrophages in breast tumors. J Exp Clin Cancer Res 2006 Sep ; 25(3):365-437.
  11. Xu W, Wang G, Zou Y, et al. VEGF expression in IDC of breast. Chinese J Of Cancer Res 2007;19(1):56-59.
  12. Yi WJ, Tang ZH, Yang ZL, et al. Difference in expression of VEGF, bFGF and their receptors between the young and postmenopausal women with breast cancer. Zhongua Zhong Liu Za Zhi 2003 March;25(2):141-145.
  13. Wang XB, Yang QX and Pei XJ. Expression of angiogenesis related factors in invasive breast cancer and its clinical significance. Nan Fang Yi Ke Da Xue Xue Bao.2006 Jun;26(6):860-863.

[Shamim Shera, Syed Imtiyaz Hussain, Shuaeb Bhat, Sumat-ul-Khurshid, Suhail Farooq, Majid Ahmad Khan, Salma Gull, Tajali Nazir Shora and Showkat Ahmad Mir (2019); EXPRESSION OF VEGF IN BREAST CANCER Int. J. of Adv. Res. 7 (Oct). 897-901] (ISSN 2320-5407). www.journalijar.com


Showkat Ahmad Mir
Department of Pathology, Government Medical College, Anantnag, Jammu & Kashmir, India.

DOI:


Article DOI: 10.21474/IJAR01/9905      
DOI URL: https://dx.doi.org/10.21474/IJAR01/9905